Cargando…
A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility
Background. Campylobacter bacteremia is an uncommon condition, usually diagnosed in elderly and immunocompromised patients. Methods. Blood culture isolates and clinical information were collected for patients with diagnoses of Campylobacter jejuni or Campylobacter coli bacteremia in Finland from 199...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174097/ https://www.ncbi.nlm.nih.gov/pubmed/21921217 http://dx.doi.org/10.1093/cid/cir509 |
_version_ | 1782212026748108800 |
---|---|
author | Feodoroff, Benjamin Lauhio, Anneli Ellström, Patrik Rautelin, Hilpi |
author_facet | Feodoroff, Benjamin Lauhio, Anneli Ellström, Patrik Rautelin, Hilpi |
author_sort | Feodoroff, Benjamin |
collection | PubMed |
description | Background. Campylobacter bacteremia is an uncommon condition, usually diagnosed in elderly and immunocompromised patients. Methods. Blood culture isolates and clinical information were collected for patients with diagnoses of Campylobacter jejuni or Campylobacter coli bacteremia in Finland from 1998 through 2007. Bacterial species were identified by means of polymerase chain reaction analysis, and minimal inhibitory concentrations for ciprofloxacin, clindamycin, doxycycline, erythromycin, gentamicin, meropenem, and metronidazole were determined with an agar dilution method. Medical records and mortality data within 1 year after the bacteremic episode were reviewed. Results. The study included 76 patients (median age, 46 years), for whom bacterial isolates (C. jejuni in 73, C. coli in 3) and clinical information were available. Most patients (70%) had no significant underlying diseases. The majority (82%) of the isolates were susceptible for all antimicrobial agents tested. However, antimicrobial therapy seemed to have only a limited effect, because no differences could be detected between patients with appropriate empirical antimicrobial treatment and those with delayed appropriate, inappropriate, or no antimicrobial therapy, either in the duration of hospitalization (median, 4 days for both groups) or in attributable mortality. The outcome of the infection was severe in 4 patients infected with C. jejuni; 2 died within 30 days, spondylodiscitis developed in 1, and Guillain-Barré syndrome developed in 1. Conclusions. C. jejuni and C. coli bacteremia occurred mainly in moderately young individuals without severe underlying diseases. The bacterial isolates were predominantly susceptible to antimicrobial agents, and the outcome of the disease was typically good, regardless of appropriate or inappropriate antimicrobial treatment given in the hospital. |
format | Online Article Text |
id | pubmed-3174097 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-31740972011-10-15 A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility Feodoroff, Benjamin Lauhio, Anneli Ellström, Patrik Rautelin, Hilpi Clin Infect Dis Electronic Articles Background. Campylobacter bacteremia is an uncommon condition, usually diagnosed in elderly and immunocompromised patients. Methods. Blood culture isolates and clinical information were collected for patients with diagnoses of Campylobacter jejuni or Campylobacter coli bacteremia in Finland from 1998 through 2007. Bacterial species were identified by means of polymerase chain reaction analysis, and minimal inhibitory concentrations for ciprofloxacin, clindamycin, doxycycline, erythromycin, gentamicin, meropenem, and metronidazole were determined with an agar dilution method. Medical records and mortality data within 1 year after the bacteremic episode were reviewed. Results. The study included 76 patients (median age, 46 years), for whom bacterial isolates (C. jejuni in 73, C. coli in 3) and clinical information were available. Most patients (70%) had no significant underlying diseases. The majority (82%) of the isolates were susceptible for all antimicrobial agents tested. However, antimicrobial therapy seemed to have only a limited effect, because no differences could be detected between patients with appropriate empirical antimicrobial treatment and those with delayed appropriate, inappropriate, or no antimicrobial therapy, either in the duration of hospitalization (median, 4 days for both groups) or in attributable mortality. The outcome of the infection was severe in 4 patients infected with C. jejuni; 2 died within 30 days, spondylodiscitis developed in 1, and Guillain-Barré syndrome developed in 1. Conclusions. C. jejuni and C. coli bacteremia occurred mainly in moderately young individuals without severe underlying diseases. The bacterial isolates were predominantly susceptible to antimicrobial agents, and the outcome of the disease was typically good, regardless of appropriate or inappropriate antimicrobial treatment given in the hospital. Oxford University Press 2011-10-15 /pmc/articles/PMC3174097/ /pubmed/21921217 http://dx.doi.org/10.1093/cid/cir509 Text en © The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please email:journals.permissions@oup.com. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Electronic Articles Feodoroff, Benjamin Lauhio, Anneli Ellström, Patrik Rautelin, Hilpi A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility |
title | A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility |
title_full | A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility |
title_fullStr | A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility |
title_full_unstemmed | A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility |
title_short | A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility |
title_sort | nationwide study of campylobacter jejuni and campylobacter coli bacteremia in finland over a 10-year period, 1998–2007, with special reference to clinical characteristics and antimicrobial susceptibility |
topic | Electronic Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174097/ https://www.ncbi.nlm.nih.gov/pubmed/21921217 http://dx.doi.org/10.1093/cid/cir509 |
work_keys_str_mv | AT feodoroffbenjamin anationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility AT lauhioanneli anationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility AT ellstrompatrik anationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility AT rautelinhilpi anationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility AT feodoroffbenjamin nationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility AT lauhioanneli nationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility AT ellstrompatrik nationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility AT rautelinhilpi nationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility |